Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer - CytoDyn (OTC:CYDY)

Summary by Benzinga
Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma  Leronlimab demonstrates synergy with standard-of-care therapies, supports plan for prospective combination study VANCOUVER, Washington, March 24, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal …

1 Articles

BenzingaBenzinga
Center

CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer - CytoDyn (OTC:CYDY)

Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma  Leronlimab demonstrates synergy with standard-of-care therapies, supports plan for prospective combination study VANCOUVER, Washington, March 24, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal …

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Tuesday, March 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Philadelphia, Pennsylvania icon

Philadelphia, Pennsylvania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal